DM² has five integrated research platforms working to deliver innovative industrial digital technologies (IDTs) that will benefit every part of the medicines manufacturing supply chain.
By focusing on cross-cutting technology solutions such as AI, machine learning, robotics and automation, the deliverables could also be adopted by multiple sectors outside of the pharmaceutical ecosystem.